Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?
Background. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected >160 million people around the world. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM) increase susceptibility to SARS-CoV-2 infection. Aims. We designed this retrospective study to ass...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/16/3740 |
id |
doaj-997ebb61159b46d1b376d52ead708e26 |
---|---|
record_format |
Article |
spelling |
doaj-997ebb61159b46d1b376d52ead708e262021-08-26T13:56:08ZengMDPI AGJournal of Clinical Medicine2077-03832021-08-01103740374010.3390/jcm10163740Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?Tiziana Ciarambino0Filippina Ciaburri1Venere Delli Paoli2Giuseppe Caruso3Mauro Giordano4Maria D’Avino5Internal Medicine Department, Hospital of Marcianise, 81037 Caserta, ItalyHypertension Unit, Cardarelli Hospital, Naples 80110, ItalyInternal Medicine Department, Cardarelli Hospital, 80110 Naples, ItalyHypertension Unit, Cardarelli Hospital, Naples 80110, ItalyInternal Medicine Department, University of Campania, L. Vanvitelli, 80110 Naples, ItalyHypertension Unit, Cardarelli Hospital, Naples 80110, ItalyBackground. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected >160 million people around the world. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM) increase susceptibility to SARS-CoV-2 infection. Aims. We designed this retrospective study to assess the gender differences in hypertensive diabetic SARS-CoV-2 patients. We reported data, by gender differences, on the inflammatory status, on the hospital stays, intensive care unit (ICU) admission, Rx and CT report, and therapy. Methods. We enrolled 1014 patients with confirmed COVID-19 admitted into different Hospitals of Campania from 26 March to 30 June, 2020. All patients were allocated into two groups: diabetic-hypertensive group (DM-HT group) that includes 556 patients affected by diabetes mellitus and arterial hypertension and the non-diabetic- non-hypertensive group (non-DM, non-HT group) comprising 458 patients. The clinical outcomes (i.e., discharges, mortality, length of stay, therapy, and admission to intensive care) were monitored up to June 30, 2020. Results. We described, in the DM-HT group, higher proportion of cardiopathy ischemic (CHD) (47.5% vs. 14.8%, respectively; <i>p</i> < 0.0001) and lung diseases in females compared to male subjects (34.8% vs. 18.5%, respectively; <i>p</i> < 0.0001). In male subjects, we observed higher proportion of kidney diseases (CKD) (11% vs. 0.01%, respectively; <i>p</i> < 0.0001), a higher hospital stay compared to female subjects (22 days vs. 17 days, respectively, <i>p</i> < 0.0001), a higher admission in ICU (66.9% vs. 12.8%, respectively, <i>p</i> < 0.0001), and higher death rate (17.3% vs. 10.7%, respectively, <i>p</i> < 0.0001). Conclusion. These data confirm that male subjects, compared to female subjects, have a higher hospital stay, a higher admission to ICU, and higher death rate.https://www.mdpi.com/2077-0383/10/16/3740COVID-19 infectiondiabetes mellitusarterial hypertensionSARS-CoV-2outcomecomorbidity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tiziana Ciarambino Filippina Ciaburri Venere Delli Paoli Giuseppe Caruso Mauro Giordano Maria D’Avino |
spellingShingle |
Tiziana Ciarambino Filippina Ciaburri Venere Delli Paoli Giuseppe Caruso Mauro Giordano Maria D’Avino Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences? Journal of Clinical Medicine COVID-19 infection diabetes mellitus arterial hypertension SARS-CoV-2 outcome comorbidity |
author_facet |
Tiziana Ciarambino Filippina Ciaburri Venere Delli Paoli Giuseppe Caruso Mauro Giordano Maria D’Avino |
author_sort |
Tiziana Ciarambino |
title |
Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences? |
title_short |
Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences? |
title_full |
Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences? |
title_fullStr |
Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences? |
title_full_unstemmed |
Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences? |
title_sort |
arterial hypertension and diabetes mellitus in covid-19 patients: what is known by gender differences? |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2021-08-01 |
description |
Background. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected >160 million people around the world. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM) increase susceptibility to SARS-CoV-2 infection. Aims. We designed this retrospective study to assess the gender differences in hypertensive diabetic SARS-CoV-2 patients. We reported data, by gender differences, on the inflammatory status, on the hospital stays, intensive care unit (ICU) admission, Rx and CT report, and therapy. Methods. We enrolled 1014 patients with confirmed COVID-19 admitted into different Hospitals of Campania from 26 March to 30 June, 2020. All patients were allocated into two groups: diabetic-hypertensive group (DM-HT group) that includes 556 patients affected by diabetes mellitus and arterial hypertension and the non-diabetic- non-hypertensive group (non-DM, non-HT group) comprising 458 patients. The clinical outcomes (i.e., discharges, mortality, length of stay, therapy, and admission to intensive care) were monitored up to June 30, 2020. Results. We described, in the DM-HT group, higher proportion of cardiopathy ischemic (CHD) (47.5% vs. 14.8%, respectively; <i>p</i> < 0.0001) and lung diseases in females compared to male subjects (34.8% vs. 18.5%, respectively; <i>p</i> < 0.0001). In male subjects, we observed higher proportion of kidney diseases (CKD) (11% vs. 0.01%, respectively; <i>p</i> < 0.0001), a higher hospital stay compared to female subjects (22 days vs. 17 days, respectively, <i>p</i> < 0.0001), a higher admission in ICU (66.9% vs. 12.8%, respectively, <i>p</i> < 0.0001), and higher death rate (17.3% vs. 10.7%, respectively, <i>p</i> < 0.0001). Conclusion. These data confirm that male subjects, compared to female subjects, have a higher hospital stay, a higher admission to ICU, and higher death rate. |
topic |
COVID-19 infection diabetes mellitus arterial hypertension SARS-CoV-2 outcome comorbidity |
url |
https://www.mdpi.com/2077-0383/10/16/3740 |
work_keys_str_mv |
AT tizianaciarambino arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences AT filippinaciaburri arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences AT veneredellipaoli arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences AT giuseppecaruso arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences AT maurogiordano arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences AT mariadavino arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences |
_version_ |
1721192312013324288 |